SciELO - Scientific Electronic Library Online

 
vol.134 número6Hepatitis C en Chile: Magnitud del problema índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

NOGALES-GAETE, Jorge; ARRIAGADA R, Camilo  y  SALINAS R, Rodrigo. Treatment of neurocysticercosis: A review. Rev. méd. Chile [online]. 2006, vol.134, n.6, pp.789-796. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000600017.

Neurocysticercosis (NCC) is the most common parasitic disease of the central nervous system. Several drugs, such as drugs against tapeworms, praziquantel or albendazole associated to corticosteroids, have been tested for the treatment of this condition. Although some have claimed the reduction or involution of cystic or granulomatous lesions, there is no consensus about the efficacy of these treatments. The natural evolution of the disease is not clear and this hampers the assessment of treatment effects. Moreover, there are no good imaging or clinical indicators that can predict the progression or spontaneous resolution of lesions, specially at the meningeal or ventricular compartment. Therefore, evidence based medicine does not have a definitive answer about the treatment, neither of seizures, the most common manifestation of NCC, or the varied and complex meningeal and ventricular involvement. This review includes experts opinions to give the clinician some clues for decision making in the treatment of NCC

Palabras clave : Albendazole; Neurocysticercosis; Praziquantel; Treatment.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons